# Precision Medicine in the CICU: Identifying Proteomic Biomarkers

> **NCT06642662** · — · ENROLLING_BY_INVITATION · sponsor: **Boston Children's Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Congenital Heart Disease

## Interventions

- **DIAGNOSTIC_TEST:** Somascan 5.0

## Key facts

- **NCT ID:** NCT06642662
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-04-15
- **Primary completion:** 2026-12-01
- **Final completion:** 2027-04-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06642662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06642662, "Precision Medicine in the CICU: Identifying Proteomic Biomarkers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06642662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*